Valicenti Advisory Services’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-34,995
| Closed | -$3.33M | – | 73 |
|
|
2024
Q3 | $3.33M | Sell |
34,995
-65
| -0.2% | -$6.18K | 0.85% | 32 |
|
|
2024
Q2 | $3.21M | Buy |
35,060
+17,655
| +101% | +$1.61M | 0.86% | 29 |
|
|
2024
Q1 | $1.58M | Sell |
17,405
-56,686
| -77% | -$5.14M | 0.44% | 48 |
|
|
2023
Q4 | $6.03M | Sell |
74,091
-5,423
| -7% | -$441K | 1.83% | 17 |
|
|
2023
Q3 | $6.35M | Buy |
79,514
+3,319
| +4% | +$265K | 2.17% | 15 |
|
|
2023
Q2 | $6M | Sell |
76,195
-5,020
| -6% | -$395K | 1.9% | 17 |
|
|
2023
Q1 | $6.31M | Buy |
81,215
+9,285
| +13% | +$721K | 2.1% | 16 |
|
|
2022
Q4 | $5.59M | Buy |
+71,930
| New | +$5.59M | 2.04% | 16 |
|